PHK
MNTA

Point72 Hong Kong’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Point72 Hong Kong’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20
Closed -$1K – 1540
2020
Q1 		$1K Buy
+20
New +$557 ﹤0.01% 892
2019
Q1 		– Sell
-1,480
Closed -$16K – 1390
2018
Q4 		$16K Buy
+1,480
New +$20.6K 0.01% 482

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Hong Kong's MNTA Position: Q2 2020 in Review

Point72 Hong Kong sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2020, closing a stake of 20 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in MNTA in Q4 2018 and held it in 2 quarters. The position peaked at $16K in Q4 2018. 237 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.

  • Point72 Hong Kong reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 20 Momenta Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1K.
  • Point72 Hong Kong first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Point72 Hong Kong's Momenta Pharmaceuticals, Inc. position peaked at $16K in Q4 2018.
  • 237 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2020.

Based on Point72 Hong Kong's 13F filing for Q2 2020, filed 14 Aug 2020.